213 related articles for article (PubMed ID: 32442170)
1. Identification of potential dual -targets anti- toxoplasma gondii compounds through structure-based virtual screening and in-vitro studies.
Salin NH; Noordin R; Al-Najjar BO; Kamarulzaman EE; Yunus MH; Karim IZA; Nasim NNM; Zakaria II; Wahab HA
PLoS One; 2020; 15(5):e0225232. PubMed ID: 32442170
[TBL] [Abstract][Full Text] [Related]
2. Screening of a library of traditional Chinese medicines to identify compounds and extracts which inhibit Toxoplasma gondii growth.
Saito H; Murata Y; Nonaka M; Kato K
J Vet Med Sci; 2020 Feb; 82(2):184-187. PubMed ID: 31904004
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship of ligands of uracil phosphoribosyltransferase from Toxoplasma gondii.
Iltzsch MH; Tankersley KO
Biochem Pharmacol; 1994 Aug; 48(4):781-92. PubMed ID: 8080452
[TBL] [Abstract][Full Text] [Related]
4. Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box.
Spalenka J; Escotte-Binet S; Bakiri A; Hubert J; Renault JH; Velard F; Duchateau S; Aubert D; Huguenin A; Villena I
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133550
[No Abstract] [Full Text] [Related]
5. Synthesis and in vitro anti-Toxoplasma gondii activity of a new series of aryloxyacetophenone thiosemicarbazones.
Ansari M; Montazeri M; Daryani A; Farshadfar K; Emami S
Mol Divers; 2020 Nov; 24(4):1223-1234. PubMed ID: 31485890
[TBL] [Abstract][Full Text] [Related]
6. In vitro anti-Toxoplasma gondii activity of root extract/fractions of Eurycoma longifolia Jack.
Kavitha N; Noordin R; Chan KL; Sasidharan S
BMC Complement Altern Med; 2012 Jul; 12():91. PubMed ID: 22781137
[TBL] [Abstract][Full Text] [Related]
7. Hydroxylamine and Carboxymethoxylamine Can Inhibit
Li J; Guo H; Galon EM; Gao Y; Lee SH; Liu M; Li Y; Ji S; Jia H; Xuan X
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31907178
[No Abstract] [Full Text] [Related]
8. Identification of compounds that suppress Toxoplasma gondii tachyzoites and bradyzoites.
Murata Y; Sugi T; Weiss LM; Kato K
PLoS One; 2017; 12(6):e0178203. PubMed ID: 28609444
[TBL] [Abstract][Full Text] [Related]
9. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS
ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728
[TBL] [Abstract][Full Text] [Related]
10. Sterculic Acid and Its Analogues Are Potent Inhibitors of Toxoplasma gondii.
Hao P; Alaraj IQ; Dulayymi JR; Baird MS; Liu J; Liu Q
Korean J Parasitol; 2016 Apr; 54(2):139-45. PubMed ID: 27180571
[TBL] [Abstract][Full Text] [Related]
11. Double-stranded RNA specific to adenosine kinase and hypoxanthine-xanthine-guanine-phosphoribosyltransferase retards growth of Toxoplasma gondii.
Yu L; Gao YF; Li X; Qiao ZP; Shen JL
Parasitol Res; 2009 Jan; 104(2):377-83. PubMed ID: 18836745
[TBL] [Abstract][Full Text] [Related]
12. Targeting Heat Shock Proteins 60 and 70 of Toxoplasma gondii as a Potential Drug Target: In Silico Approach.
Ashwinder K; Kho MT; Chee PM; Lim WZ; Yap IK; Choi SB; Yam WK
Interdiscip Sci; 2016 Dec; 8(4):374-387. PubMed ID: 26297309
[TBL] [Abstract][Full Text] [Related]
13. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.
Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F
Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321
[TBL] [Abstract][Full Text] [Related]
14. Recent progress on anti-Toxoplasma drugs discovery: Design, synthesis and screening.
Deng Y; Wu T; Zhai SQ; Li CH
Eur J Med Chem; 2019 Dec; 183():111711. PubMed ID: 31585276
[TBL] [Abstract][Full Text] [Related]
15. 7-Deaza-6-benzylthioinosine analogues as subversive substrate of Toxoplasma gondii adenosine kinase: activities and selective toxicities.
Al Safarjalani ON; Rais RH; Kim YA; Chu CK; Naguib FN; el Kouni MH
Biochem Pharmacol; 2008 Oct; 76(8):958-66. PubMed ID: 18755159
[TBL] [Abstract][Full Text] [Related]
16. A protein extract and a cysteine protease inhibitor enriched fraction from Jatropha curcas seed cake have in vitro anti-Toxoplasma gondii activity.
Soares AM; Carvalho LP; Melo EJ; Costa HP; Vasconcelos IM; Oliveira JT
Exp Parasitol; 2015 Jun; 153():111-7. PubMed ID: 25816973
[TBL] [Abstract][Full Text] [Related]
17. Phytochemicals and Potential Therapeutic Targets on Toxoplasma gondii Parasite.
Abdullahi SA; Unyah NZ; Nordin N; Basir R; Nasir WM; Alapid AA; Hassan Y; Mustapha T; Majid RA
Mini Rev Med Chem; 2020; 20(9):739-753. PubMed ID: 31660810
[TBL] [Abstract][Full Text] [Related]
18. Adenosine metabolism in Toxoplasma gondii: potential targets for chemotherapy.
el Kouni MH
Curr Pharm Des; 2007; 13(6):581-97. PubMed ID: 17346176
[TBL] [Abstract][Full Text] [Related]
19. Antiprotozoal activity of auranofin on Trypanosoma cruzi, Leishmania tropica and Toxoplasma gondii: in vitro and ex vivo study.
Yıldırım A; Özbilgin A; Yereli K
Trans R Soc Trop Med Hyg; 2023 Oct; 117(10):733-740. PubMed ID: 37377375
[TBL] [Abstract][Full Text] [Related]
20. Deciphering ophthalmic adaptive inhibitors targeting RON4 of Toxoplasma gondii: An integrative in silico approach.
Vetrivel U; Nagarajan H
Life Sci; 2018 Nov; 213():82-93. PubMed ID: 30326220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
